The Oncology Institute is involved in providing value-based oncology care. The Oncology Institute, formerly known as DFP Healthcare Acquisitions Corp., is based in NEW YORK.
| Revenue (Most Recent Fiscal Year) | $393.41M |
| Net Income (Most Recent Fiscal Year) | $-64.66M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.71 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 56.31 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -15.96% |
| Net Margin (Trailing 12 Months) | -15.38% |
| Return on Equity (Trailing 12 Months) | -445.02% |
| Return on Assets (Trailing 12 Months) | -34.13% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.79 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.59 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 14.58 |
| Inventory Turnover (Trailing 12 Months) | 31.42 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.06 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.70 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Common Shares Outstanding | 89.23M |
| Free Float | 81.65M |
| Market Capitalization | $286.44M |
| Average Volume (Last 20 Days) | 1.64M |
| Beta (Past 60 Months) | 0.04 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 8.50% |
| Percentage Held By Institutions (Latest 13F Reports) | 36.86% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |